Susan Morse
Technology, including AI, should serve data as the foundation for the optimal patient experience, says Noyo National Practice Leader Gary Davis.
Nicole Clawson of Pennsylvania Mountain Healthcare Alliance talks about finding the right adoption model ahead of her session at HIMSS24.
Clearway Health, born out of Boston Medical Center, acts as project manager for gene therapy access, says chief pharmacy officer.
Impacted payers need to send prior authorization decisions within 72 hours for urgent requests and seven days for standard requests.
The technology falsely tagged consumers, particularly women and people of color, as shoplifters, FTC says.
Lifestyle is a bigger factor in how long we live than science, innovation and curative therapies, says Andy Davis of Deloitte.
Heading into 2024, companies face elevated interest rates, weak liquidity and no appetite from lenders for highly-leveraged capital structures.
American Medical Association President Dr. Jesse Ehrenfeld is a keynote speaker at the HIMSS AI in Healthcare Forum.
Providers focused on access, treatment; payers looking at affordability; and innovators trying new therapies, need to get together, says Micah Litow.
Ardent proactively took its network offline, suspending all user access to its IT applications, including corporate servers and Epic software.